Description
| Product ID: | 9781264277841 |
| Product Form: | Cards |
| Country of Manufacture: | GB |
| Title: | McGraw Hill's 2024/2025 Top 300 Pharmacy Drug Cards |
| Authors: | Author: Jill Kolesar, Lee C. Vermeulen |
| Page Count: | 608 |
| Subjects: | Medicine: general issues, Medicine: general issues |
| Description: | Select Guide Rating The quickest, most efficient way to master critical facts about common drugs Perfect for NAPLEX and course review, McGraw Hill's 2024/2025 Top 300 Pharmacy Drug Cards is the most concise and up-to-date resource for building a solid knowledge base of the most commonly used drugs. Adverse reactions are organized by common, less common, and rare but serious to help users organize thoughts for counseling patients. This updated edition includes 30 new cards as well as downloadable files featuring audio Q&A to help you study. Each card features: •Generic and common name•Dosage Forms•Approved Dose and Indications•Off-Label Use•Contraindications•Adverse Reactions•Drug Interactions•Monitoring Parameters•Medication Safety Issues and Black Box Warnings•Strong focus on patient safety The quickest, most efficient way to master critical facts about common drugs Perfect for NAPLEX and course review, McGraw Hill''s 2024/2025 Top 300 Pharmacy Drug Cards is the most concise and up-to-date resource for building a solid knowledge base of the most commonly used drugs. Adverse reactions are organized by common, less common, and rare but serious to help users organize thoughts for counseling patients. This updated edition includes 30 new cards as well as downloadable files featuring audio Q&A to help you study. Each card features: •Generic and common name •Dosage Forms •Approved Dose and Indications •Off-Label Use •Contraindications •Adverse Reactions •Drug Interactions •Monitoring Parameters •Medication Safety Issues and Black Box Warnings •Strong focus on patient safety |
| Imprint Name: | McGraw-Hill Education |
| Publisher Name: | McGraw-Hill Education |
| Country of Publication: | GB |
| Publishing Date: | 2024-01-12 |
